Sign in

CIK 0001137883

  • Non-accelerated filer
  • Smaller reporting company

BRAINSTORM CELL THERAPEUTICS INC.

Sign in to watch
Ticker
BCLI
Exchange
OTC
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
207273918
Phone
+1 201-488-0460
Business address
1325 AVENUE OF AMERICAS, 28TH FLOOR, NEW YORK, NY, 10019
Former names
BRAINSTORM CELL THERAPEUTICS INC, GOLDEN HAND RESOURCES INC, WIZBANG TECHNOLOGIES INC
  1. 4 Open-market sale Chief Financial Officer sold 100,000 shares at $0.36 ($36,000)
  2. 4 Open-market sale Chief Financial Officer sold 150,000 shares at $0.36 ($54,000)
  3. 5 Insider Annual Insider Trading Report
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 3 Insider Initial Statement of Ownership
  9. 4/A Insider Changes in Ownership
  10. 4/A Other acquisition Director acquired 0 shares (other)
  11. 4 Open-market sale Director sold 40,000 shares at $0.25 ($10,000)
  12. 4 Exercise or conversion 10% owner acquired 2,000,000 shares (option exercise)
  13. 4 Exercise or conversion 10% owner acquired 4,125,000 shares (option exercise)
  14. 4 Derivatives Options or other derivatives
  15. 4 Shares withheld for taxes Former Director gave up 100,000 shares (to pay taxes)
  16. 4 Derivatives Options or other derivatives
  17. 4 Shares withheld for taxes Director gave up 100,000 shares (to pay taxes)
  18. 3 Insider Initial Statement of Ownership
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 14 of 17 · 329 filings